The document provides a comprehensive overview of airborne particulate particle size, including definitions and statistical measures such as mass median aerodynamic diameter (mmad) and geometric standard deviation (gsd). It discusses the physiological effects of inhalable, thoracic, and respirable particles, along with guidelines for airborne sampling and the importance of understanding deposition sites and particle characteristics. Additionally, it highlights research on the toxicokinetics and effects of poorly soluble particulate, emphasizing the potential for pulmonary overload and impaired clearance in chronic exposure scenarios.